StockData

Regenerative Medical Technology Group Inc. (RMTG) stock

RMTGOTCRetail-Retail Stores, NECFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 3/30
$0.04−0.00 (-5.76%)

Close on Oct 19, 2026Market cap $497.25KP/E –Yield –

Regenerative Medical Technology ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Regenerative Medical Technology's ebitda for the twelve months ending Jun 30, 2026 was $406.65K, down 10.2% year over year. For fiscal 2025 it was -$586.10K, down 294.2% from the year before.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$586.10K-294.2%
FY2024Dec 31, 2024$301.74K–
FY2023Dec 31, 2023-$405.12K–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$656.79K–
Q1 FY2026Mar 31, 2026$327.48K+75.3%
Q4 FY2025Dec 31, 2025-$207.93K-158.9%
Q3 FY2025Sep 30, 2025-$369.68K-440.8%
Q2 FY2025Jun 30, 2025-$195.26K–
Q1 FY2025Mar 31, 2025$186.77K–
Q4 FY2024Dec 31, 2024$352.81K–
Q3 FY2024Sep 30, 2024$108.48K–
Q2 FY2024Jun 30, 2024-$131.01K–
Q1 FY2024Mar 31, 2024-$28.53K–

More Regenerative Medical Technology figures

See a number that looks wrong?